These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

678 related items for PubMed ID: 15301560

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A, Tardif JC.
    Adv Cardiol; 2006; 43():65-78. PubMed ID: 16936473
    [Abstract] [Full Text] [Related]

  • 6. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W, Tendera M, Ford I, Fox KM.
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The discovery of the selective I(f) current inhibitor ivabradine. A new therapeutic approach to ischemic heart disease.
    Vilaine JP.
    Pharmacol Res; 2006 May; 53(5):424-34. PubMed ID: 16638639
    [Abstract] [Full Text] [Related]

  • 18. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH.
    J Am Coll Cardiol; 2013 Oct 08; 62(15):1330-8. PubMed ID: 23916925
    [Abstract] [Full Text] [Related]

  • 19. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Oct 08; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 20. Ivabradine: an intelligent drug for the treatment of ischemic heart disease.
    Riccioni G.
    Molecules; 2012 Nov 16; 17(11):13592-604. PubMed ID: 23159921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.